Ideas

Natural product-based exercise mementics therapy for Metabolic disease: Magnolol, isolated from Magnolia Officinalis, increases PPARδ  and Foxo1 levels, inhibits glucose catabolism, preserves glucose levels, stimulates FA catabolism, delays the onset of hypoglycemia and boosts endurance exercise via down regulation of its target gene, 15/December/2017, 9.54 am

Natural product-based exercise mementics therapy for Metabolic disease: Magnolol, isolated from Magnolia Officinalis, increases PPARδ  and Foxo1 levels, inhibits glucose catabolism, preserves glucose levels, stimulates FA catabolism, delays the onset of hypoglycemia and boosts endurance exercise via down regulation of its target gene, 15/December/2017, 9.54 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say  A study from Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA shows that “CRY1/2 Selectively Repress…

read more

Vitamin-based therapy for body weight control, energy homeostasis and TIIDM: Folic acid, a form of Vitamin-B (9), decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 15/December/2017, 9.35 am

Vitamin-based therapy for body weight control, energy homeostasis and TIIDM: Folic acid, a form of Vitamin-B (9), decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 15/December/2017, 9.35 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by neuronal cell adhesion molecule1.”…

read more

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Efavirenz and Ritonavir (ER) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 15/December/2017,  9.23 am

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Efavirenz and Ritonavir (ER) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 15/December/2017,  9.23 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Molecular therapy for inflammation and arthritis: Diclofenac [Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren], a nonsteroidal anti-inflammatory drug, increases IL-9 levels, increases proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up regualtion of its target genes, 15/December/2017, 9.10 am

Molecular therapy for inflammation and arthritis: Diclofenac [Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren], a nonsteroidal anti-inflammatory drug, increases IL-9 levels, increases proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up regualtion of its target genes, 15/December/2017, 9.10 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Vitamin-based therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Pyridoxamine (PM), a form of Vitamin-B6, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene Lin28, 14/December/2017, 1.22 am

Vitamin-based therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Pyridoxamine (PM), a form of Vitamin-B6, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene Lin28, 14/December/2017, 1.22 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:   A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates glucose metabolism.” This study…

read more

Vitamin-based therapy for Stroke: Vitamin-B6 attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 14/December/2017, 1.14 am

Vitamin-based therapy for Stroke: Vitamin-B6 attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 14/December/2017, 1.14 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; and School of Public…

read more